Used in cancer research, particularly as a tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFRs). It helps block angiogenesis, the process by which tumors develop new blood vessels to support their growth. By inhibiting this pathway, it has been investigated for its potential to suppress tumor progression in various solid tumors, including colorectal and glioblastoma cancers. It is primarily employed in preclinical studies to evaluate anti-angiogenic therapies and to understand signaling pathways involved in tumor development.